US FDA clarifies reporting of serious adverse events for cosmetics

Updated MoCRA guidance for industry

The FDA finalised draft guidance released in August on registration and listing requirements for cosmetic facilities and products. The guidance includes a new draft appendix meant to answer queries about the entities and items covered under MoCRA. For instance, it...
US FDA clarifies reporting of serious adverse events for cosmetics

USA MoCRA Update

The United States FDA is currently developing systems and processes to enable companies to comply with the new MoCRA requirements, including the process to submit: Facility registrations Product listings The system should be available in October 2023 On 7 August 2023,...